Feng Ren

Feng Ren

Director Ejecutivo en INSILICO MEDICINE CAYMAN TOPCO .

Fortuna: 8 M $ al 31/07/2026

51 años
Consumer Services
Health Technology
Commercial Services

Perfil

Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/07/2026 1.288.055 ( 0,22 % ) 8 M $ 31/07/2026

Cargos activos de Feng Ren

EmpresasCargoInicio
INSILICO MEDICINE CAYMAN TOPCO Director Ejecutivo 01/06/2022
Director Ejecutivo -

Antiguos cargos conocidos de Feng Ren.

EmpresasCargoFin
SHANGHAI MEDICILON INC. Corporate Officer/Principal 01/01/2021
GSK PLC Director/Miembro de la Junta 01/01/2018
Ver el detalle de la experiencia de Feng Ren.

Formación de Feng Ren.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

93

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Technology Services

Health Technology